BEGIN:VCALENDAR VERSION:2.0 PRODID:-//PsychU - ECPv6.1.4//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:PsychU X-ORIGINAL-URL:https://psychu.org X-WR-CALDESC:Events for PsychU REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20230312T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20231105T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20240328T120000 DTEND;TZID=America/New_York:20240328T130000 DTSTAMP:20240329T003352 CREATED:20240228T183146Z LAST-MODIFIED:20240228T183151Z UID:10004039-1711627200-1711630800@psychu.org SUMMARY:Comorbidities In Patients Living With Bipolar I Disorder DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Lifetime comorbidity rates in bipolar disorder are ~90%\, and nearly half of these patients are treated for a minimum of three1. During this webinar\, Otsuka Sr. MSL Dr. Michael Aldape will be talking with Dr. Joseph Goldberg who will guide us on a lively discussion addressing the complexities of psychiatric comorbidities associated with bipolar I disorder. This moderated session will explore common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n\n\n1. Altinbas\, K. Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder. Noro Psikiyatr Ars. 2021 Sep 20;58 (Suppl 1): S41-S46. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Joseph Goldberg\, MD\n Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai\n \n \n \n More\n \n Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder\, as well as three books on bipolar disorder and psychopharmacology.\n \n \n\n\n \n \n \n \n Michael Aldape\, PhD (OPDC)\n Senior Medical Science Liaison \n \n \n \n\n\nSpeaker Joseph F Goldberg\, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Michael Aldape\, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/comorbidities-in-patients-living-with-bipolar-i-disorder/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/02/Shutterstock_138065606.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240228T120000 DTEND;TZID=America/New_York:20240228T123000 DTSTAMP:20240329T003353 CREATED:20240103T183318Z LAST-MODIFIED:20240228T174807Z UID:10004008-1709121600-1709123400@psychu.org SUMMARY:Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Current evidence-based guidelines for the diagnosis and treatment of post-traumatic stress disorder (PTSD) are valuable resources and can be used to help develop individual treatment plans for patients. This webinar will examine the current PTSD treatment landscape\, including discussions on both psychotherapy and pharmacotherapy. In addition\, presenters will review limitations and key considerations in the treatment of PTSD. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n David Block\, MD\, MMM\, FAPA\n Clinical Assistant Professor of Psychiatry\, Western University of Health Sciences\, Loma Linda University and California University of Health and Medicine; Private Practitioner\, Costa Mesa\, CA \n \n \n More\n \n Dr. David Block\, a psychiatrist in Orange County\, CA\, is dual board-certified in psychiatry and addiction medicine and was elected to become a Fellow of the American Psychiatric Association in January 2014. Currently\, he is the Clinical Assistant Professor of Psychiatry at the Western University of Health Sciences\, Loma Linda University and California University of Health and Medicine\, and is a Private Practitioner in Costa Mesa\, CA.\n\nDr. Block has worked extensively in college mental health\, managed health care\, and community treatment settings with severely and persistently mentally ill individuals. He has extensive clinical experience working with individuals with PTSD\, from both his public and private sector work\, Additionally\, he has written several articles in the psychiatric literature and taught seminars and lectures to students training in the mental health professions. \n\n \n \n\n\n \n \n \n \n Madeline Shurtleff\, PharmD (OPDC)\n Managed Market Liaison \n \n \n More\n \n Dr. Shurtleff is a clinical pharmacist with experience in managed care and retail pharmacy. She has extensive knowledge in Medicaid and Medicare pharmacy operations and regulatory requirements. Dr. Shurtleff received her Doctor of Pharmacy (PharmD)\, Business Minor\, and Leadership Minor from the University of Rhode Island. She is a licensed pharmacist in Illinois and Arizona.\n \n \n\n\nDavid Block\, MD\, MMM\, FAPA is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc.Madeline Shurtleff\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/exploring-post-traumatic-stress-disorder-treatment-landscape-unmet-needs/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/01/Shutterstock_2387841697.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240222T120000 DTEND;TZID=America/New_York:20240222T130000 DTSTAMP:20240329T003353 CREATED:20240123T152031Z LAST-MODIFIED:20240222T164957Z UID:10004018-1708603200-1708606800@psychu.org SUMMARY:Let’s Face It\, The Current Treatment Options For MDD Are Not Enough: Learn About Cognitive Emotional Training DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n During an expert interview\, Otsuka Sr. MSL\, Dr. Mark Tacelosky will be talking with Dr. Brian Iacoviello who will guide us through Cognitive Emotional Training for the treatment of major depressive disorder (MDD). The objectives of this activity include providing the rationale for the role of cognitive-emotional training\, exploring the steps for developing a cognitive-emotional training intervention for the treatment of MDD\, reviewing the options for the digital delivery of cognitive emotional training\, and discussing the possibilities for future research and applications. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Brian Iacoviello\, PhD\n Assistant Professor\, Icahn School of Medicine at Mount Sinai New York\, NY\n \n \n \n More\n \n Dr. Iacoviello is a clinical psychologist and assistant professor at the Icahn School of Medicine at Mount Sinai. He earned his Masters and PhD in clinical psychology from Temple University in PA. Dr Iacoviello specializes in treating mood and anxiety disorders\, using cognitive behavioral therapy\, dialectical behavior therapy\, acceptance and commitment therapy and motivational interviewing. His research delves into understanding fundamental cognitive behavioral patterns associated with depression\, bipolar disorder\, and anxiety disorders to search for novel treatments\n \n \n\n\n \n \n \n \n Mark Tacelosky\, PharmD (OPDC)\n Senior Medical Science Liaison \n \n \n \n\n\nBrian Iacoviello\, PhD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Mark Tacelosky\, PharmD is an employee for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/lets-face-it-the-current-treatment-options-for-mdd-are-not-enough-learn-about-cognitive-emotional-training/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2024/01/Shutterstock_2410022633.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240221T183000 DTEND;TZID=America/New_York:20240221T203000 DTSTAMP:20240329T003353 CREATED:20240112T145240Z LAST-MODIFIED:20240202T162421Z UID:10004012-1708540200-1708547400@psychu.org SUMMARY:Unmet Needs In Agitation Associated With Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD. \n \n\n\n\n\n\n\n \n Venue\n \n \n\n\n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n George Alexopoulos\, MD\n DeWitt Wallace Distinguished Scholar\, Founding Director\, Weill Cornell Institute of Geriatric Psychiatry\, Weill Cornell Medicine \n \n \n \n\n\n \n \n \n \n Jehan Marino\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Erika Modh\, PharmD\, BCPS (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker George Alexopoulos\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speakers Jehan Marino\, PharmD\, BCPP and Erika Modh\, PharmD\, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\nPSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS \n PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.\, Otsuka America Pharmaceutical\, Inc.\, and Lundbeck\, L.L.C.\, committed supporters of the mental health treatment community; as such\, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs. \n PSYCHU MEMBERSHIP ELIGIBILITY \n In accordance with the PhRMA Code on Interactions with Healthcare Professionals\, attendance at PsychU educational programs is limited to appropriate attendees (e.g.\, physician\, clinical professional\, current medical school student\, care manager\, advocate\, recovery coach or an executive and manager of an organization) whose primary role is to provide\, manage\, finance\, study\, or regulate mental health services for adult patients.\n NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements. \n MEMBERSHIP & REGISTRATION \n Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU\, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program\, please visit https://www.PsychU.org/. \n ATTENDANCE LIMITATIONS \n PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs\, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs\, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions\, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com. \n MEAL REPORTING \n The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws. URL:https://psychu.org/event/unmet-needs-in-agitation-associated-with-alzheimers-dementia-aad-2/ LOCATION:Lusardi’s\, 1885 Palmer Ave\, Larchmont\, NY\, 10538\, United States CATEGORIES:Live Event ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Live-Event_912x506_shutterstock_1352113667.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240220T123000 DTEND;TZID=America/New_York:20240220T130000 DTSTAMP:20240329T003353 CREATED:20240117T192514Z LAST-MODIFIED:20240119T190048Z UID:10004015-1708432200-1708434000@psychu.org SUMMARY:Virtual Event - Inadequately Treated Major Depressive Disorder (MDD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in Arkansas\, Indiana\, Kentucky\, Louisiana\, Mississippi\, Texas\, and West Virginia. \nIn this presentation\, the objectives are to: \n\nDescribe the prevalence of depression in the US\nHighlight the burden of MDD\nIdentify inadequately treated MDD and understand how it impacts patients\nUnderstand which patients are at risk for inadequately treated MDD\nExplain MDD treatment strategies \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Lindsey Wright\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Amaka Onyereri\, PharmD\, BCPS (OPDC)\n Medical Science Liaison \n \n \n More\n \n Amaka Onyereri received her bachelor’s degree in general science and Doctor of Pharmacy degree from Oregon State University/Oregon Health Sciences University. Her passion for patient care led her to practice clinically as a community pharmacist where she served patients for close to 20 years in different capacities as a staff pharmacist\, pharmacy manager and pharmacy clinical services manager.\nAs a Pharmacy Clinical Services Manager\, Amaka spearheaded various clinical and patient care initiatives such as immunizations\, medication therapy management\, point of care testing\, and most recently a long-acting injectables pilot for antipsychotics.\n \n \n\n\nSpeakers Lindsey Wright\, PharmD and Amaka Onyereri\, PharmD\, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-inadequately-treated-major-depressive-disorder-mdd-2/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240201T150000 DTEND;TZID=America/New_York:20240201T160000 DTSTAMP:20240329T003353 CREATED:20240108T210042Z LAST-MODIFIED:20240201T220305Z UID:10004011-1706799600-1706803200@psychu.org SUMMARY:Virtual Event - Born This Way? The Role Of Early Life Stress In Adult Mental Illness DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n https://forms.office.com/r/XmfW5c5MvQ\n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n In this presentation\, the objectives are to: \n\nRecognize early life adversity as a risk factor for the development of psychiatric illness across diagnostic boundaries\nCharacterize biological and neurobiological mechanisms that implicate childhood trauma and stress in adult mental illness\nUnderstand the importance of assessing early life events in the clinical setting \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Chet Robachinski\, MD\n Psychiatric Director\, Bailey-Boushay House\, Seattle\, WA; Founding Partner\, Associates in Behavioral Health \n \n \n \n\n\n \n \n \n \n Simon Kim\, PharmD (OPDC)\n Medical & Scientific Liaison \n \n \n \n\n\nSpeaker Chet Robachinski\, MD is a paid employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Simon Kim\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-born-this-way-the-role-of-early-life-stress-in-adult-mental-illness/ LOCATION:VA CATEGORIES:National,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231213T150000 DTEND;TZID=America/New_York:20231213T160000 DTSTAMP:20240329T003353 CREATED:20231107T162058Z LAST-MODIFIED:20231213T222722Z UID:10004001-1702479600-1702483200@psychu.org SUMMARY:Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer’s Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers (HCPs)2\,3. Early identification\, management and treatment of AAD has been shown to improve patient outcomes and reduce caregiver burden4\,5\, highlighting the importance of a strong therapeutic alliance between care partners and HCPs. In this webinar\, geriatric psychiatrist\, Dr. Marc Agronin\, and care partner\, Carrie Shaw\, share their unique but complimentary perspectives on identifying and responding to agitation and navigating the shared decision-making process. Our speakers will discuss best practices for how to effectively prepare for and communicate during an appointment and what tools and resources are available for care partners. One such tool they review is the AASC™\, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders6\, which was designed to assist caregivers in recognizing AAD.\n\n\nClick here to register for the 12:00 pm EST broadcast\n\n\nReferences:\n\n Stella F\, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237\n Lindeza P\, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242.\n Gallego-Alberto L\, et al. Clin Gerontol. 2022;45(5):1295-1303.\n Hoe J\, et al. BJPsych Open. 2017;3(1):34-40.\n Janzen S\, et al. Am J Alzheimers Dis Other Demen. 2013;28(5):524-532\n Sano M\, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Marc E. Agronin\, MD\n Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine \n \n \n \n\n\n \n \n \n \n Carrie Shaw\, MD\n CEO & Founder of Embodied Labs \n \n \n \n\n\n \n \n \n \n Miranda Fisher\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n\n\n\n\nMarc Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Miranda Fisher\, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/conversations-matter-the-importance-of-effective-communication-between-healthcare-providers-care-partners-of-individuals-living-with-agitation-in-alzheimers-dementia-aad-3pm/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/11/Son-and-Elderly-Father_Conversation_Alzheimers_912x506_shutterstock_2070560411.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231213T120000 DTEND;TZID=America/New_York:20231213T130000 DTSTAMP:20240329T003353 CREATED:20231107T162104Z LAST-MODIFIED:20231213T210333Z UID:10004002-1702468800-1702472400@psychu.org SUMMARY:Conversations Matter: The Importance Of Effective Communication Between Healthcare Providers & Care Partners Of Individuals Living With Agitation In Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers (HCPs)2\,3. Early identification\, management and treatment of AAD has been shown to improve patient outcomes and reduce caregiver burden4\,5\, highlighting the importance of a strong therapeutic alliance between care partners and HCPs. In this webinar\, geriatric psychiatrist\, Dr. Marc Agronin\, and care partner\, Carrie Shaw\, share their unique but complimentary perspectives on identifying and responding to agitation and navigating the shared decision-making process. Our speakers will discuss best practices for how to effectively prepare for and communicate during an appointment and what tools and resources are available for care partners. One such tool they review is the AASC™\, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders6\, which was designed to assist caregivers in recognizing AAD.\n\n\nClick here to register for the 3:00 pm EST broadcast\n\n\nReferences:\n\n Stella F\, et al. Int J Geriatr Psychiatry. 2015;30(12):1230-1237\n Lindeza P\, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242.\n Gallego-Alberto L\, et al. Clin Gerontol. 2022;45(5):1295-1303.\n Hoe J\, et al. BJPsych Open. 2017;3(1):34-40.\n Janzen S\, et al. Am J Alzheimers Dis Other Demen. 2013;28(5):524-532\n Sano M\, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Marc E. Agronin\, MD\n Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine \n \n \n \n\n\n \n \n \n \n Carrie Shaw\, MD\n CEO & Founder of Embodied Labs \n \n \n \n\n\n \n \n \n \n Miranda Fisher\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n\n\n\n\nMarc Agronin and Carrie Shaw are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) Miranda Fisher\, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/conversations-matter-the-importance-of-effective-communication-between-healthcare-providers-care-partners-of-individuals-living-with-agitation-in-alzheimers-dementia-aad-12pm/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/11/Son-and-Elderly-Father_Conversation_Alzheimers_912x506_shutterstock_2070560411.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231211T120000 DTEND;TZID=America/New_York:20231211T130000 DTSTAMP:20240329T003353 CREATED:20230914T191514Z LAST-MODIFIED:20231107T152141Z UID:10003983-1702296000-1702299600@psychu.org SUMMARY:Virtual Event - Unmet Needs In Agitation Associated With Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, North Carolina\, South Carolina\, and Virginia. \nThis evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Chris Brodie\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Justin Wimmer\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeakers Chris Brodie\, PhD and Justin Wimmer\, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-unmet-needs-in-agitation-associated-with-alzheimers-dementia-aad-4/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231205T120000 DTEND;TZID=America/New_York:20231205T130000 DTSTAMP:20240329T003353 CREATED:20231006T151153Z LAST-MODIFIED:20231107T151813Z UID:10003994-1701777600-1701781200@psychu.org SUMMARY:Virtual Event - Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in Florida and Georgia. \nIn this presentation\, the objectives are to: \n\nUnderstand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes\nDiscuss risk factors for mood episode recurrence\, including nonadherence\, in patients with bipolar I disorder\n\nReview management strategies\, including long-acting injectable antipsychotics (LAIs)\, to optimize patient outcomes in bipolar I disorder \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Larry Reccoppa\, MD\n Regional Psychiatric Director\, Wellpath; Staff Psychiatrist\, Behavioral Health Services CMHC \n \n \n \n\n\n \n \n \n \n Aneta Fornal\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Larry Reccoppa\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Aneta Fornal\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-strategies-to-optimize-patient-outcomes-in-bipolar-i-disorder-role-of-long-acting-injectable-antipsychotics-2/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231201T120000 DTEND;TZID=America/New_York:20231201T130000 DTSTAMP:20240329T003353 CREATED:20230830T125421Z LAST-MODIFIED:20231107T151750Z UID:10003984-1701432000-1701435600@psychu.org SUMMARY:Virtual Event - Recognizing & Responding To Inadequately Treated Major Depressive Disorder DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, and Virginia. \nIn this presentation\, the objectives are to: \n\nDiscuss the burden of MDD on the individual and society\nExplore the negative impact of residual symptoms\nIdentify patient and treatment characteristics associated with a poor treatment response\nDiscuss strategies to optimize pharmacotherapy \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Dennis Sholler\, PhD (OPDC)\n Senior Medical Science Liaison\, CNS \n \n \n \n\n\nSpeaker Dennis Sholler\, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-recognizing-responding-to-inadequately-treated-major-depressive-disorder/ LOCATION:Sheraton Erie Bayfront Hotel\, 55 West Bay Drive\, Erie\, PA\, 16507\, United States CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231129T120000 DTEND;TZID=America/New_York:20231129T130000 DTSTAMP:20240329T003353 CREATED:20231030T203117Z LAST-MODIFIED:20231129T164726Z UID:10003999-1701259200-1701262800@psychu.org SUMMARY:The Agitation In Alzheimer's Screener For Caregivers (AASC™) - A New Tool To Disease Recognition DESCRIPTION:Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Agitation is one of the most common neuropsychiatric symptoms of Alzheimer’s dementia\, and one of the most complex\, prominent\, stressful\, and costly aspects of care.1 Caregivers are often first to encounter agitation-associated behaviors and play a pivotal role in communicating these symptoms to healthcare providers (HCPs).2\,3 Agitation associated with Alzheimer’s dementia (AAD) causes a significant clinical\, humanistic\, and economic burden on community\, family\, and professional caregivers.4\,5\,6\,7 AAD is notably underdiagnosed\, and most caregivers do not identify the breadth of signs/symptoms of agitation and are hesitant to discuss these behaviors with HCPs.8 Therefore\, there’s a need for an easy\, pragmatic screener to facilitate caregiver recognition of AAD and HCP discussions. AASC™\, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders\,9 was designed to assist caregivers in recognizing AAD. Dr. Carolyn Clevenger will discuss development of the AASC™ tool and its potential to improve communication between caregivers and providers\, and ultimately recognition of agitation behaviors.\nReferences: \n\n\n Halpern R\, et al. Int J Geriatr Psychiatry. 2019;34(3):420-431\n Lindeza P\, et al. BMJ Support Palliat Care. 2020; bmjspcare-2020-002242\n Gallego-Alberto L\, et al. Clin Gerontol. 2022;45(5):1295-1303\n Fillit H\, et al. Int J Geriatr Psychiatry. 2021 ;36(12) :1959-1969\n Jones E\, et al. J Alzheimers Dis. 2021 ;83(1) :89-101\n Schein J\, et al. J Alzheimers Dis. 2022 ;88(2) :663-677\n Palm R\, et al. J Alzheimers Dis. 2018 ;66(4) :1463-1470\n Lanctot KL\, et al. Alzheimers Dement (NY). 2017 ;3(3) :440-449\n Sano M\, et al. International Psychogeriatrics 2023 :1-13. doi10.1017/S1041610222001041\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Carolyn Clevenger\, DNP\, RN\, GNP-BC\, AGPCNP-BC\, FAANP\, FGSA\n Professor of Transformative Clinical Practice\, Emory University School of Nursing\, Clinical Director and Gerontological Nurse Practitioner at Integrated Memory Care Clinic \n \n \n More\n \n Carolyn Clevenger DNP\, RN\, GNP-BC\, AGPCNP-BC\, FAANP\, FGSA\, is Professor of Transformative Clinical Practice at the Emory University School of Nursing in Atlanta\, Georgia. She serves as Clinical Director and Gerontological Nurse Practitioner at Emory’s Integrated Memory Care Clinic\, a patient-centered medical home providing integrated memory care and primary care for persons living with dementia. She is a Past President of the Gerontological Advanced Practice Nurses Association\, and Fellow of the American Association of Nurse Practitioners (AANP) and the Gerontological Society of America.\n \n \n\n\n \n \n \n \n Mike Crooks\, PharmD\, BCGP (OPDC)\n Senior Long-Term Care Medical Science Liaison \n \n \n \n\n\nSpeaker Carolyn Clevenger DNP\, RN\, GNP-BC\, AGPCNP-BC\, FAANP\, FGSA is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Moderator Mike Crooks\, Pharm D\, BCGP is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. \n \n \n \n \n \n \n\n\n\n\n \n \n \n Home\n \n \n \n \n Events URL:https://psychu.org/event/the-agitation-in-alzheimers-screener-for-caregivers-aasc-a-new-tool-to-disease-recognition/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/10/Assessment-Tool_Agitation-in-Alzheimers_912x506_shutterstock_716614579.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231115T120000 DTEND;TZID=America/New_York:20231115T130000 DTSTAMP:20240329T003353 CREATED:20231019T151436Z LAST-MODIFIED:20240116T172341Z UID:10003997-1700049600-1700053200@psychu.org SUMMARY:Exploring Post-Traumatic Stress Disorder: Disease Burden DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Post-traumatic stress disorder (PTSD) has a high impact on quality of life\, which can negatively affect patient outcomes and relationships with others. These patients also have an increased risk of medical comorbidities and mortality\, increasing the burden on the healthcare system and society. This virtual event will further examine the patient\, humanistic\, clinical\, and economic burden of PTSD. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n David Purselle\, MD\, MSCR\n Board-certified psychiatrist with over 20 years of clinical experience\, Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine \n \n \n More\n \n Dr. David Purselle is a board-certified psychiatrist with over 20 years of clinical experience working in a variety of settings\, including outpatient clinics\, emergency rooms\, and inpatient units at the Atlanta VA Medical Center\, Emory University Hospital\, and Grady Hospital. Currently\, he is the Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine. He is also involved with several clinical research studies studying the effectiveness of various antidepressants\, mood stabilizers\, antipsychotics\, and lithium.\n\n\nDr. Purselle has been recognized as a physician leader in several forums and presented continuing medical education programs at national and local conferences. He has also served as a consultant for major pharmaceutical corporations providing guidance on development of new therapies for a variety of mental illnesses.\n \n \n\n\n \n \n \n \n Erika Modh\, PharmD\, BCPS (OPDC)\n Medical Science Liaison \n \n \n \n\n\n\n\n\n\nDavid Purselle is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) Erika Modh is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/exploring-post-traumatic-stress-disorder-disease-burden/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/10/PTSD_912x506_shutterstock_1977078593.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231113T120000 DTEND;TZID=America/New_York:20231113T130000 DTSTAMP:20240329T003353 CREATED:20230914T191351Z LAST-MODIFIED:20231228T162121Z UID:10003985-1699876800-1699880400@psychu.org SUMMARY:Virtual Event - Disease State Education: Treatment & Current Treatment Guidelines - Agitation Associated With Alzheimer’s Dementia DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, North Carolina\, South Carolina\, and Virginia. \nIn this presentation\, topics of discussion are: \n\nDiscuss treatment plans are recommended for patients with Alzheimer’s disease\nDiscuss comprehensive management plan\nDiscuss unmet needs for treatment of agitation in Alzheimer’s dementia \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Chris Brodie\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Justin Wimmer\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeakers Chris Brodie\, PhD and Justin Wimmer\, PharmD employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-disease-state-education-treatment-current-treatment-guidelines-agitation-associated-with-alzheimers-dementia/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231109T120000 DTEND;TZID=America/New_York:20231109T130000 DTSTAMP:20240329T003353 CREATED:20231019T151157Z LAST-MODIFIED:20231109T211454Z UID:10003996-1699531200-1699534800@psychu.org SUMMARY:Walking The Tight Rope: A Discussion Of Striking The Right Balance In Depression\, With A Focus On Norepinephrine DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Join us for a PsychU webinar with Drs. Vladimir Maletic\, Craig Chepke\, and Jason Carter as they discuss the potential role of norepinephrine in Major Depressive Disorder\, as part of the monoaminergic theory of depression. \n\nDespite the efficacy of first-line anti-depressant treatments in MDD\, many individuals continue to experience unresolved symptoms that may impair their daily functioning and increase the healthcare burden. In fact\, the STAR*D study demonstrated approximately one third of patients with MDD achieved remission following treatment with first-line antidepressants\, highlighting the need to address unresolved and persistent symptoms of depression.1 Recent studies have shown that norepinephrine\, a neurotransmitter which regulates concentration\, energy levels\, and arousal\, may play a crucial role in the persistence of depression symptoms.2 \n\nOur webinar aims to provide valuable insights into the complex nature of depression and the potential role of norepinephrine in the pathophysiology of depression. \n\n \n\nReferences:\n\n Rush AJ et al. Am J Psychiatry. 2006;163:1905-1917\n Maletic V\, et al. Front Psychiatry. 2017;8:42.\n \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Vladimir Maletic\, MD\n Serves as Clinical Professor\, Psychiatry/Behavioral Science\, University of South Carolina School of Medicine Greenville\, SC \n \n \n More\n \n Vladimir Maletic\, MD serves as Clinical Professor\, Psychiatry/Behavioral Science\, School of Medicine Greenville\, SC and has been rated as Best Doctors of the America Registry and Psychiatrist of the year. Dr. Maletic received the Upjohn Achievement Award and Student Council teaching award and faculty award for teaching achievement. He also has received the Medical School Award for Academic Achievement.\n \n \n\n\n \n \n \n \n Craig Chepke\, MD\, FAPA\n Board-Certified Psychiatrist\, Fellow of the American Psychiatric Association\, Private practice at Excel Psychiatric Associates in Huntersville\, NC\, Adjunct Associate Professor of Psychiatry for Atrium Health and University of North Carolina School of Medicine \n \n \n More\n \n Excel Psychiatric Associates\, Atrium Health\, and University of North Carolina School of Medicine Dr. Chepke is a Board-Certified psychiatrist and a Fellow of the American Psychiatric Association. He has a private practice at Excel Psychiatric Associates in Huntersville\, NC and serves as an Adjunct Associate Professor of Psychiatry for Atrium Health and an Adjunct Assistant Professor of Psychiatry for the University of North Carolina School of Medicine. He has special interests in treatment-resistant and severe mental illness\, movement disorders\, ADHD\, and sleep medicine. Dr. Chepke is a member of the Huntington Study Group and serves on the board of directors for the CURESZ foundation\, a nonprofit organization dedicated to improving the lives of people living with Schizophrenia\n \n \n\n\n \n \n \n \n Jason Carter\, PharmD (OPDC)\n Senior Medical Science Liaison\, Neuroscience Field Medical Affairs \n \n \n \n\n\n\n\n\n\nVladimir Maletic and Craig Chepke are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Jason Carter is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/walking-the-tight-rope-a-discussion-of-striking-the-right-balance-in-depression-with-a-focus-on-norepinephrine/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/10/Depression_Psychiatrist_patient_912x506_shutterstock_2093817313.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231107T180000 DTEND;TZID=America/New_York:20231107T200000 DTSTAMP:20240329T003353 CREATED:20231026T205908Z LAST-MODIFIED:20231030T185334Z UID:10003998-1699380000-1699387200@psychu.org SUMMARY:Considerations & Factors For Switching & Augmenting Medications For Major Depressive Disorder DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Live Event for PsychU Members in West Virginia. \nIn this presentation\, the objectives are to: \n\nTo discuss treatment challenges and guidelines for treating major depressive disorder (MDD)\nTo consider recommendations from the literature regarding making a treatment change for patients with partial or non-response to current treatment\nTo understand considerations from the literature regarding switch vs. augmentation as a treatment strategy for patients with partial or non-response\nTo explore physician determinants of use of antipsychotic treatment augmentation for patients with MDD \n \n\n\n\n\n\n\n \n Venue\n \n \n\n\n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Lindsey Wright\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Lindsey Wright\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\nPSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS \n PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.\, Otsuka America Pharmaceutical\, Inc.\, and Lundbeck\, L.L.C.\, committed supporters of the mental health treatment community; as such\, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs. \n PSYCHU MEMBERSHIP ELIGIBILITY \n In accordance with the PhRMA Code on Interactions with Healthcare Professionals\, attendance at PsychU educational programs is limited to appropriate attendees (e.g.\, physician\, clinical professional\, current medical school student\, care manager\, advocate\, recovery coach or an executive and manager of an organization) whose primary role is to provide\, manage\, finance\, study\, or regulate mental health services for adult patients.\n NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements. \n MEMBERSHIP & REGISTRATION \n Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU\, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program\, please visit https://www.PsychU.org/. \n ATTENDANCE LIMITATIONS \n PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs\, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs\, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions\, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com. \n MEAL REPORTING \n The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws. URL:https://psychu.org/event/considerations-factors-for-switching-augmenting-medications-for-major-depressive-disorder/ LOCATION:21 at the Frederick\, 940 4th Ave\, Huntington\, WV\, 25701\, United States CATEGORIES:Live Event ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Live-Event_912x506_shutterstock_1352113667.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231107T120000 DTEND;TZID=America/New_York:20231107T130000 DTSTAMP:20240329T003353 CREATED:20230831T211052Z LAST-MODIFIED:20231107T221105Z UID:10003986-1699358400-1699362000@psychu.org SUMMARY:Virtual Event - Inadequately Treated Major Depressive Disorder (MDD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a National Virtual Event for all PsychU members. \nIn this presentation\, the objectives are to: \n\nDescribe the prevalence of depression in the US\nHighlight the burden of MDD\nIdentify inadequately treated MDD and understand how it impacts patients\nUnderstand which patients are at risk for inadequately treated MDD\nExplain MDD treatment strategies \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Christine Costa\, Ph.D.\, DNP\, RN\, PMHNP-BC\n Psychiatric Nurse practitioner\, Gateways Hospital and Mental Health Center \n \n \n More\n \n Dr. Costa is a psychiatric nurse practitioner with over 20 years of experience in the health field\, currently working for Gateways Hospital and Mental Health Center. She serves as an Associate Professor at California State University\, Long Beach School of Nursing. Costa received her Doctor of Philosophy from William Carey University in Hattiesburg\, Mississippi\, and a Doctor of Nursing Practice from Brandman University in Irvine\, California.\n \n \n\n\n \n \n \n \n Elika Hefazi\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Christine Costa\, Ph.D.\, DNP\, RN\, PMHNP-BC is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Elika Hefazi\, PharmD\, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-inadequately-treated-major-depressive-disorder-mdd/ LOCATION:Sheraton Erie Bayfront Hotel\, 55 West Bay Drive\, Erie\, PA\, 16507\, United States CATEGORIES:National,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231103T120000 DTEND;TZID=America/New_York:20231103T130000 DTSTAMP:20240329T003353 CREATED:20230830T125159Z LAST-MODIFIED:20231103T161336Z UID:10003982-1699012800-1699016400@psychu.org SUMMARY:Virtual Event - Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, and Virginia. \nIn this presentation\, the objectives are to: \nExplore the overlapping monoaminergic pathways\nExamine the overlapping monoaminergic circuitry\nDescribe the brain norepinephrine system including the distribution of adrenergic receptors in the brain\nDescribe how norepinephrine signaling may directly and indirectly modulate dopamine and serotonin activity\nExplore the proposed therapeutic areas where modulation of norepinephrine signaling may be clinically relevant \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Dennis Sholler\, PhD (OPDC)\n Senior Medical Science Liaison\, CNS \n \n \n \n\n\nSpeaker Dennis Sholler\, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-proposed-roles-of-modulating-norepinephrine-in-psychiatric-illnesses-2/ LOCATION:Sheraton Erie Bayfront Hotel\, 55 West Bay Drive\, Erie\, PA\, 16507\, United States CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20231019T183000 DTEND;TZID=America/Los_Angeles:20231019T210000 DTSTAMP:20240329T003353 CREATED:20231002T233432Z LAST-MODIFIED:20231219T004404Z UID:10003992-1697740200-1697749200@psychu.org SUMMARY:Major Depressive Disorder In Chronic Kidney Disease DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Live Event for PsychU members in California. \nIn this presentation\, the objectives are to: \n\nOverview of Major Depressive Disorder (MDD) and Chronic Kidney Disease (CKD)/End Stage Renal Disease (ESRD).\nDiscuss the high prevalence of depression in patients with CKD\nDiscuss how overlap of symptomatology between MDD and CKD makes diagnosing depression in the setting of CKD challenging.\nDiscuss the association of MDD with poor outcomes in CKD.\nDiscuss potential risk factors and mechanism of MDD in CKD.\nDiscuss the cycle between MDD and ESRD.\nAddress challenges in MDD management considerations in CKD patients. \n \n\n\n\n\n\n\n \n Venue\n \n \n\n\n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Elika Hefazi\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Marla Dallal\, PharmD\, RPH\n Clinical & Scientific Liaison (Nephrology) \n \n \n More\n \n Marla Dallal\, PharmD\, RPH is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California\, School of Pharmacy in Los Angeles. While in pharmacy school\, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka\, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc\, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.\n \n \n\n\nSpeakers Elika Hefazi\, PharmD\, BCPP and Marla Dallal\, PharmD\, RPH are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\nPSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS \n PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.\, Otsuka America Pharmaceutical\, Inc.\, and Lundbeck\, L.L.C.\, committed supporters of the mental health treatment community; as such\, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs. \n PSYCHU MEMBERSHIP ELIGIBILITY \n In accordance with the PhRMA Code on Interactions with Healthcare Professionals\, attendance at PsychU educational programs is limited to appropriate attendees (e.g.\, physician\, clinical professional\, current medical school student\, care manager\, advocate\, recovery coach or an executive and manager of an organization) whose primary role is to provide\, manage\, finance\, study\, or regulate mental health services for adult patients.\n NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements. \n MEMBERSHIP & REGISTRATION \n Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU\, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program\, please visit https://www.PsychU.org/. \n ATTENDANCE LIMITATIONS \n PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs\, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs\, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions\, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com. \n MEAL REPORTING \n The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws. URL:https://psychu.org/event/major-depressive-disorder-in-chronic-kidney-disease-3/ LOCATION:Il Fornaio\, 1800 Rosecrans Ave Ste F\, Manhattan Beach\, CA\, 90266\, United States CATEGORIES:Live Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231019T120000 DTEND;TZID=America/New_York:20231019T130000 DTSTAMP:20240329T003353 CREATED:20230728T163342Z LAST-MODIFIED:20231019T210516Z UID:10003381-1697716800-1697720400@psychu.org SUMMARY:Virtual Event - Unmet Needs In Agitation Associated With Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Live Event for PsychU members in Florida and Georgia. \nThis evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis of AAD. We will also explore the potential pathobiological correlations in AAD\, describe the clinical and humanistic burden as well as current guidelines for treatments of this complex and prominent complication of an already devastating disease. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Marc E. Agronin\, MD\n Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine \n \n \n \n\n\n \n \n \n \n Aneta Fornal\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Marc Agronin\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) Speaker Aneta Fornal\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-unmet-needs-in-agitation-associated-with-alzheimers-dementia-aad-2/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231016T120000 DTEND;TZID=America/New_York:20231016T130000 DTSTAMP:20240329T003353 CREATED:20230914T191108Z LAST-MODIFIED:20240220T221040Z UID:10003987-1697457600-1697461200@psychu.org SUMMARY:Virtual Event - Agitation Associated With Alzheimer’s Dementia Disease State Education DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, North Carolina\, South Carolina\, and Virginia. \nIn this presentation\, topics of discussion are: \n\nAlzheimer’s disease is highly prevalent\, under-diagnosed\, and predicted to increase significantly in the coming decades due to an aging population\nAgitation is a common neuropsychiatric symptom of Alzheimer’s dementia and highly prevalent across patient settings and Alzheimer’s disease severities\nThe Cohen-Mansfield Agitation Inventory (CMAI) measures the frequency of manifestations of a broad range of agitated behaviors \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Chris Brodie\, PhD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Justin Wimmer\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeakers Chris Brodie\, PhD and Justin Wimmer\, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-agitation-associated-with-alzheimers-dementia-disease-state-education-2/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231016T120000 DTEND;TZID=America/New_York:20231016T130000 DTSTAMP:20240329T003353 CREATED:20230913T200130Z LAST-MODIFIED:20240220T205130Z UID:10003989-1697457600-1697461200@psychu.org SUMMARY:Exploring Post-Traumatic Stress Disorder: Trauma\, Trends & Diagnostic Insights DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n The global effects of trauma\, both physiologically and psychologically on individuals\, are extensive. This webinar will examine the prevalence of post-traumatic stress disorder (PTSD)\, explore trauma types\, review important screening and diagnostic tools\, and delve into the complexities encountered during the initial presentation and subsequent assessment PTSD. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Saundra Jain\, MA\, PsyD\, LPC\n Adjunct Clinical Affiliate for the School of Nursing at the University of Texas\, Austin; Co-founder of WILD-5 Wellness® \n \n \n More\n \n Saundra Jain is an Adjunct Clinical Affiliate for the School of Nursing at The University of Texas\, Austin\, Texas. She is very focused on wellness and the impact of positive psychology on client outcomes. She launched a private practice of psychotherapy where she currently provides services for a wide range of mental health issues.\n\n\nDr. Jain is a co-creator of the WILD 5 Wellness Program\, which combines five elements of wellness (exercise\, mindfulness\, sleep\, social connectedness\, and nutrition) into a prescriptive\, easy-to-follow wellness program. She is very active in the area of peer-to-peer education\, especially in the disease states of depression\, bipolar disorder\, anxiety disorders\, and ADHD. She is the co-creator and co-presenter of a novel interactive workshop addressing the challenges of dealing with psychiatric co-morbidities through the use of psychiatric scales and screeners. She also serves as a member of the Psych Congress Committee providing direction regarding educational gaps & needs for healthcare practitioners in the world of mental health.\n\n\nCo-founder WILD-5 Wellness®\n \n \n\n\n \n \n \n \n Elika Hefazi\, PharmD\, BCPP (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSaundra Jain is a paid consultant of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Elika Hefazi is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/exploring-post-traumatic-stress-disorder-trauma-trends-diagnostic-insights/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/09/shutterstock_2180809683-e1696468373203.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231011T120000 DTEND;TZID=America/New_York:20231011T130000 DTSTAMP:20240329T003353 CREATED:20230623T174515Z LAST-MODIFIED:20231011T203042Z UID:10003974-1697025600-1697029200@psychu.org SUMMARY:The Impact Of Adherence In Patients With Bipolar I Disorder DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Treatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion\, Dr. Sajatovic and Dr. Goldberg will discuss and define some of these challenges and provide the latest information on treatment-related determinants of adherence. They will also discuss some of the factors important to adherence. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Martha Sajatovic\, MD\n Psychiatrist\, Director Neurological and Behavioral Outcomes Center\, University Hospital Cleveland Medical Center and Professor\, Case Western Reserve University School of Medicine \n \n \n More\n \n Martha Sajatovic\, MD holds the Willard Brown Chair in Neurological Outcomes at University Hospitals Cleveland Medical Center (UH CMC) and the Rocco L. Motto Professorship in Child & Adolescent Psychiatry. Dr. Sajatovic directs the Neurological and Behavioral Outcomes Center at UHCMC/Case Western Reserve University. She has subspecialty certification in Behavioral Neurology & Neuropsychiatry. Dr. Sajatovic is a Professor of Psychiatry and Neurology at Case Western Reserve University School of Medicine (CWRU) in Cleveland\, Ohio. Dr. Sajatovic is a researcher\, educator\, and clinician who has devoted herself to studying and treating traditionally\, hard-to-treat populations with central nervous system disorders. Dr. Sajatovic’s research interests have focused on neuropsychiatric outcomes of brain disorders across the life-span\, including epilepsy\, stroke\, Alzheimer’s disease\, and other types of dementia and Parkinson’s disease. She has authored or co-authored over 250 peer-reviewed publications and has published over 40 book chapters or books on neuropsychiatric topics. Dr. Sajatovic has been a recipient of the Exemplary Psychiatrist Award bestowed by the National Alliance for the Mentally Ill (NAMI)\, was a Depression and Bipolar Support Alliance (DBSA) Gerald Klerman Investigator Award winner in 2006 and 2016\, and in 2018 received the Rebecca Goldberg Kaufman American Epilepsy Society (AES) Clinical Award in Ethical Neuropsychiatry.\n \n \n\n\n \n \n \n \n Joseph Goldberg\, MD\n Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai\n \n \n \n More\n \n Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder\, as well as three books on bipolar disorder and psychopharmacology.\n \n \n\n\n \n \n \n \n Elizabeth DiNapoli\, PhD (OPDC)\n Senior Medical Science Liaison \n \n \n More\n \n Dr. DiNapoli earned her PhD from the University of Alabama.\n \n \n\n\nSpeakers Martha Sajatovic\, MD and Joseph Goldberg\, MD are paid consultants for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC)Speaker Elizabeth DiNapoli\, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/the-impact-of-adherence-in-patients-with-bipolar-i-disorder/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/06/Shutterstock_1918015181.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231006T120000 DTEND;TZID=America/New_York:20231006T130000 DTSTAMP:20240329T003353 CREATED:20230830T125102Z LAST-MODIFIED:20231011T162043Z UID:10003980-1696593600-1696597200@psychu.org SUMMARY:Virtual Event - Plasma Concentrations\, Pharmacokinetics & Their Clinical Relevance DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in DC\, Maryland\, and Virginia. \nUnderstanding pharmacokinetics is important for determining an effective and safe treatment plan. The objectives of this presentation are to provide an overview of pharmacokinetics (PK) and pharmacodynamics (PD)\, describe the differences in PK and plasma concentrations of different medication formulations (oral and long-acting injectable (LAI))\, and explain the importance of PK and plasma concentrations in the clinical setting. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Dennis Sholler\, PhD (OPDC)\n Senior Medical Science Liaison\, CNS \n \n \n \n\n\nSpeaker Dennis Sholler\, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-plasma-concentrations-pharmacokinetics-their-clinical-relevance/ LOCATION:Sheraton Erie Bayfront Hotel\, 55 West Bay Drive\, Erie\, PA\, 16507\, United States CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231005T120000 DTEND;TZID=America/New_York:20231005T130000 DTSTAMP:20240329T003354 CREATED:20230919T202927Z LAST-MODIFIED:20231006T200134Z UID:10003981-1696507200-1696510800@psychu.org SUMMARY:Behavioral Health Quality Trends Affecting Payers DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n The evolving trends of mental healthcare quality measures have a marked impact on payers. Join Molly Burich and Madeline Shurtleff in this discussion that will review current behavioral health quality measures\, social determinations of health\, and the outcome each has on payers. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Molly Burich\, (OPDC)\n Senior Director\, Reimbursement & Health Policy\, Government Affairs\, Otsuka America Pharmaceutical\, Inc. \n \n \n \n\n\n \n \n \n \n Madeline Shurtleff\, PharmD (OPDC)\n Managed Market Liaison \n \n \n More\n \n Dr. Shurtleff is a clinical pharmacist with experience in managed care and retail pharmacy. She has extensive knowledge in Medicaid and Medicare pharmacy operations and regulatory requirements. Dr. Shurtleff received her Doctor of Pharmacy (PharmD)\, Business Minor\, and Leadership Minor from the University of Rhode Island. She is a licensed pharmacist in Illinois and Arizona.\n \n \n\n\nMolly Burich & Madeline Shurtleff are employees of Otsuka American Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/behavioral-health-quality-trends-affecting-payers/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/09/Quality-Trends-Affecting-Payers_912x506_shutterstock_1029998605-e1698951603907.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231004T120000 DTEND;TZID=America/New_York:20231004T130000 DTSTAMP:20240329T003354 CREATED:20230825T172513Z LAST-MODIFIED:20231004T161700Z UID:10003393-1696420800-1696424400@psychu.org SUMMARY:Virtual Event - Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in Florida and Georgia. \nIn this presentation\, the objectives are to: \n\nUnderstand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes\nDiscuss risk factors for mood episode recurrence\, including nonadherence\, in patients with bipolar I disorder\nReview management strategies\, including long-acting injectable antipsychotics (LAIs)\, to optimize patient outcomes in bipolar I disorder \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Dante Durand\, MD\, MBA\n Vice Chair of Clinical Services & Associate Professor\, Department of Psychiatry and Behavioral Sciences\, University of Miami Miller School of Medicine; Chief Medical Officer at Jackson Behavioral Health Hospital in Miami\, FL. \n \n \n More\n \n Dr. Dante Durand is an Associate Professor and the Vice-Chair of Clinical Services for the Department of Psychiatry at the University of Miami Miller School of Medicine. He is also the Chief Medical Officer at Jackson Behavioral Health Hospital. Dr. Durand’s area of clinical and research interest is schizophrenia. He has written several scientific articles and is the principal investigator on multiple clinical trials in this area. As faculty member\, Dr. Durand has been involved in the education of future generation of psychiatrists and due to his teaching abilities\, he has received multiple honors such as the University of Miami\, Department of Psychiatry Senior Teaching Award for 5 consecutive years. Dr. Durand is a fellow of the American Psychiatric Association\, a member of the American College of Psychiatrists and a board examiner of the American Board of Psychiatry and Neurology.\n \n \n\n\n \n \n \n \n Aneta Fornal\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeaker Dante Durand\, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) Speaker Aneta Fornal\, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-strategies-to-optimize-patient-outcomes-in-bipolar-i-disorder-role-of-long-acting-injectable-antipsychotics/ LOCATION:Joey’s\, 200 Oak Hill Ave\, Endicott\, NY\, 13760\, United States CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230927T123000 DTEND;TZID=America/New_York:20230927T133000 DTSTAMP:20240329T003354 CREATED:20230818T143746Z LAST-MODIFIED:20230927T203631Z UID:10003391-1695817800-1695821400@psychu.org SUMMARY:Virtual Event - Unmet Needs In Agitation Associated With Alzheimer's Dementia (AAD) DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n This is a Virtual Event for PsychU members in Illinois\, Kentucky\, Missouri\, and West Virginia. \nThis evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis of AAD. We will also explore the potential pathobiological correlations in AAD\, describe the clinical and humanistic burden as well as current guidelines for treatments of this complex and prominent complication of an already devastating disease. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Kavita Saini\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\n \n \n \n \n Lindsey Wright\, PharmD (OPDC)\n Medical Science Liaison \n \n \n \n\n\nSpeakers Kavita Saini\, PharmD and Lindsey Wright\, PharmD are employees of Otuska Pharmaceutical Development and Commercialization\, Inc. (OPDC) \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/virtual-event-unmet-needs-in-agitation-associated-with-alzheimers-dementia-aad-3/ LOCATION:VA CATEGORIES:Regional/Local,Virtual & Live Events ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/04/Virtual-Event_912x506_shutterstock_2069741450.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230927T120000 DTEND;TZID=America/New_York:20230927T130000 DTSTAMP:20240329T003354 CREATED:20230804T204626Z LAST-MODIFIED:20230927T203404Z UID:10003383-1695816000-1695819600@psychu.org SUMMARY:Suicide Awareness & Prevention: PsychU Resource Review & Discussion DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n The PsychU community is cordially invited to join Drs. Amica Simmons-Yon and Rachel Self as they discuss the critically important topic of suicide awareness and prevention. An overview of resources available on PsychU as well as some of the leading national organizations devoted to suicide awareness and prevention will be provided. Appropriate language\, ongoing initiatives\, screening tools\, and navigation through materials on PsychU will also be highlighted. We all have a role to play in increasing suicide awareness\, providing support\, and directing individuals in need to potentially life-saving resources. Join us for this opportunity to learn and grow as we all strive to improve our mental health… together! \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Amica Simmons-Yon\, PharmD\, PhD (OPDC)\n Senior Medical Science Liaison\, Neuroscience Field Medical Affairs \n \n \n \n\n\n \n \n \n \n Rachel Self\, PhD\, MS (OPDC)\n Medical Science Director\, Neuroscience Field Medical Affairs \n \n \n More\n \n \n\nRachel Self\, PhD\, MS is a Medical Science Director for Otsuka’s Neuroscience Field Medical Affairs\, neuroscientist\, & wellness advocate\n\n\n \n \n\n\nAmica Simmons-Yon and Rachel Self are employees of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC) \n\n\n\nIf you or someone you know is in crisis\,call 988 or the Suicide Prevention Hotline/Lifeline 1-800-273-TALK(8255)or text the Crisis Text Line 741-741 \n\n\n\n\n\n\n\n \n Related Resources\n \n \n\n\n\n\n\n\nPsychU Suicide Awareness Resources:Suicide Awareness – PsychU \n\n\n\nPsychU 988 Webinar:988: What’s The Scoop? A Discussion With Experts In Suicide Prevention & Mental Health – PsychU \n\n\n\nSuicide Prevention Resource Center:https://sprc.org/ \n\n\n\nAmerican Foundation for Suicide Prevention: Become an Advocate:Advocate for suicide prevention | AFSP \n\n\n\nPsychU Interview on Stahl’s Clinical Handbook Suicide Prevention Edition:Stahl’s Handbook Suicide Prevention Edition: An Interview With Drs. Christine Moutier & Anthony Pisani – PsychU \n\n\n\n988 Update Analysis:One Year After the Launch of 988\, the National Suicide and Crisis Hotline Has Received Nearly 5 Million Combined Calls\, Texts\, and Chats | KFF \n\n\n\nPsychU Suicide Prevention Brochure:Download Brochure \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/suicide-awareness-prevention-psychu-resource-review-discussion/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/08/Depression_group-therapy_912x506_shutterstock_2321772109.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230913T120000 DTEND;TZID=America/New_York:20230913T130000 DTSTAMP:20240329T003354 CREATED:20230816T203054Z LAST-MODIFIED:20230914T160627Z UID:10003385-1694606400-1694610000@psychu.org SUMMARY:Defining\, Clarifying\, & Implementing Digital Tools For Mental Health DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n\n \n \n \n\n \n \n \n \n \n \n\n \n\n\n\n \n \n \n \n \n \n \n \n\n\n\n \n Thank You For Attending Today’s Webinar\n Please tell us what you thought about today’s presentation by taking the survey below: \n \n \n \n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n Digital tools are one of the newest therapeutic modalities for the prevention\, management\, or treatment of chronic\, behavior-modifiable disease.1 In this webinar\, Dr. Jake Behrens and Dr. Margaret Emerson will share their expertise in the utilization of digital tools. Together\, they will define digital health tools\, clarify their potential application in clinical practice\, and describe digital tool implementation best practices.\n\n\nObjectives: \n• Define Digital Heath Tools\n• Clarify the Application of Digital Tools in Mental Health Treatment\n• Outline the Implementation of Digital Tools in Clinical Practice\n\n1 Patel NA\, Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics NPJ Digit Med.2020;3:159. \n \n\n\n\n\n\n\n \n Featuring\n \n \n\n\n \n \n \n \n Jake Behrens\, MD\n CEO & Medical Director\, Regional Director\nEnvision ADHD\, Brightside Health \n \n \n \n\n\n \n \n \n \n Margaret Emerson\, DNP\, APRN\, PMHNP-BC\n Clinical Associate Professor at the University of Nebraska Medical Center\, Omaha\, NE \n \n \n More\n \n Dr. Margaret Emerson is a Clinical Associate Professor at the University of Nebraska Medical Center\, which is the site where she completed her Bachelor\, Master and Doctorate degrees. Dr. Emerson has extensive expertise in the development and delivery of Integrated and Collaborative care modalities in a variety of clinical environments. Notably she was one of the first psychiatric mental health nurse practitioners in the state of Nebraska to serve in the psychiatric consultant role. Her research efforts have focused on improving access to care among the underserved patient populations within the integrative environments through the use of mobile technology. As a result of this work she was selected as an expert panelist for the American Psychiatric Association App Advisory Panel. She is regularly an invited speaker and consultant across the United States to disseminate her expertise in integrated care and use of technology. She most recently was awarded an American Rescue Plan Act grant enabling her to develop one of the first integrated care student health clinics in rural Nebraska. This grant focuses on technology and tailored training to promote exposure and interest in these delivery models.\n \n \n\n\n \n \n \n \n Jason Carter\, PharmD (OPDC)\n Senior Medical Science Liaison\, Neuroscience Field Medical Affairs \n \n \n \n\n\nDr. Jake Behrens and Dr. Margaret Emerson are paid consultants of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \nDr. Jason Carter is an employee of Otsuka Pharmaceutical Development & Commercialization\, Inc. (OPDC). \n\n\n\n\n\n\n\n\n\n\n\n \n Registration\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/defining-clarifying-implementing-digital-tools-for-mental-health/ LOCATION:VA CATEGORIES:Webinar ATTACH;FMTTYPE=image/jpeg:https://psychu.org/wp-content/uploads/2023/08/Digital-Health_912x506-e1695928625612.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20230803T074500 DTEND;TZID=America/Los_Angeles:20230804T153000 DTSTAMP:20240329T003354 CREATED:20230714T180746Z LAST-MODIFIED:20230718T213313Z UID:10003978-1691048700-1691163000@psychu.org SUMMARY:Leadership & Management In Geriatrics DESCRIPTION:Home\n \n \n \n \n Events\n \n \n \n \n \n\n\n\n\n About This Event\n \n \n \n \n \n \n \n \n \n \n Inadequately Treated Major Depressive Disorder (MDD)\n August 3-4 & 11\, 2023 | Live Virtual Event\nSponsored by Supporting Organization: California Association of Long Term Care Medicine (CALTCM) \nThis three-day course affords participants the opportunity to spend time in an intensive and highly interactive setting with leaders in the field of geriatric medical management and an exclusive two-month post-course mentorship. Participants are encouraged to think “outside of the box” and consider novel approaches to creating and managing geriatric clinics\, practices\, and services. A unique feature of the conference is the opportunity for participants to work in small collaborative groups with a faculty mentor to develop and implement an action plan for a management/leadership challenge. CME and CE units are available to all participants\, and additional credits are awarded to those who complete a post-course mentorship project. \n \n\n\n\nRegister\n\n\n\n\n\n\n\n\n \n Related Resources\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Comorbidities In Patients Living With Bipolar I Disorder\n \n On-Demand Webinar March 28\, 2024\n \n This moderated session explores common comorbidities\, treatment options and the current guidelines for managing comorbid bipolar I patients. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Saklad\n \n Interview March 27\, 2024\n \n Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him. \n \n \n What World Bipolar Day Means To Me Featuring Dr. Goldberg\n \n Interview March 26\, 2024\n \n Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him. URL:https://psychu.org/event/leadership-management-in-geriatrics/ LOCATION:VA CATEGORIES:Supporter Event ATTACH;FMTTYPE=image/png:https://psychu.org/wp-content/uploads/2023/07/LMG-2023-Web-Banner_912x506.png END:VEVENT END:VCALENDAR